Loading provider…
Loading provider…
Medical Oncology Physician in Falls Church, VA
NPI: 1003851460Primary Employer
Inova Fairfax Hospital
inova.org
HQ Phone
Get M.D., PH.D. Michael's Phone Numberphone_androidMobile
Get M.D., PH.D. Michael's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardIL State Medical License
VA State Medical License
Sorafenib inhibits neuroblastoma cell proliferation and signaling, blocks angiogenesis, and impairs tumor growth.
Authors: Susan Cohn, Radhika Peddinti, Nisha Kakodkar
Publication Date: 2012-10
Estimation of renal cell carcinoma treatment effects from disease progression modeling.
Authors: Maitland, M L, Wu, K, Sharma, M R, Jin, Y, Kang, S P, Stadler, W M, Karrison, T G, Ratain, M J, Bies, R R
Journal: Clin Pharmacol Ther
Publication Date: 2012-12-27
Authors: Richard Carvajal, Hao Yang, Michael Postow, Geoffrey Oxnard, Lawrence Schwartz, Volkan Beylergil
Journal: JAMA Oncol
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: Carboplatin, DRUG: Vorinostat, OTHER: Laboratory Biomarker Analysis, OTHER: Pharmacological Study, DRUG: Paclitaxel
Lead Sponsor: NRG Oncology
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Laboratory Biomarker Analysis, DRUG: Copanlisib
Lead Sponsor: National Cancer Institute (NCI)
Collaborators: NRG Oncology
Intervention / Treatment: BIOLOGICAL: Bevacizumab, OTHER: Quality-of-Life Assessment, DRUG: Atezolizumab, PROCEDURE: Computed Tomography, DRUG: Pegylated Liposomal Doxorubicin Hydrochloride